|
The client was part of a team responsible for identifying
and prioritizing commercially attractive market needs.
The client also needed to understand how multitier co-pays,
pharmaceutical spending accounts and other factors influenced
patients' product choices within and across diseases.
In addition to the traditional view of identifying clinical
unmet needs, the client wanted to understand unmet treatment
needs from a patient's perspective.
The client engaged MattsonJack to better understand the market and
to combine the patient's view with the clinical assessment
for a broader perspective of needs. Comprehending the patient's
perspective would provide a more complete analysis of unmet
needs for the identification of future development opportunities.
|
MattsonJack conducted qualitative interviews with patients in each
area to formulate patient-centric language and issues.
Samples were recruited to reflect the epidemiology of each
disease by race, age and gender. Internet surveys were conducted
with patients in 21 disease areas, covering the following
topics:
- quality-of-life evaluation
- medications taken, both prescription and non-prescription
- ancillary non-medication, health-related programs
- treatment goals and ability to achieve goals
- satisfaction / frustration with treatments in general
and other healthcare factors
- payment methods for prescription pharmaceuticals
To help define the opportunity, patients' unmet needs were
assessed across diseases based on the extent of health and
emotional unmet need in relation to the size of the population
of each disease.
Results then were compared to physicians' perspectives (in
a different, concurrent project) to assess opportunities that
were not identified previously.
The final deliverable included normative comparisons, using
scales from clinical research approaches to assess health
and quality of life.
|
